Membranoproliferative glomerulonephritis historical perspective: Difference between revisions
Aditya Ganti (talk | contribs) No edit summary |
Aditya Ganti (talk | contribs) |
||
| (5 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Membranoproliferative glomerulonephritis}} | {{Membranoproliferative glomerulonephritis}} | ||
{{CMG} | {{CMG}} ; {{AE}} | ||
==Overview== | ==Overview== | ||
The term membranous glomerulonephritis was used first by Bell in 1946 to describe a category of [[glomerular]] renal disease classified within the spectrum of Ellis type II glomerulonephritis. This category also included [[lipoid nephrosis]], lobular glomerulonephritis, and chronic glomerulonephritis. In 1957, David Jones, a renal pathologist from Syracuse University in New York, separated membranous glomerulonephritis as a distinct morphologic entity. Jones fully illustrated the special features of this lesion such as lobular glomerulonephritis, lipoid nephrosis and chronic glomerulonephritis. Thickening of the capillary wall and alteration in [[basement membrane]] structure were described. Electron-dense subepithelial locations were identified by Movat and McGregor in 1959 using electron microscopic methods. Mellors in 1957 identified the unique lesion of membranous glomerulonephritis, the presence of immunoglobulin in the deposits, using the immunofluorescence technique. Thus, over the span of just 2 years, the triad of essential features of membranous glomerulonephritis were described. These are still the fundamental features used today to identify membranous glomerulonephritis, now called membranoproliferative glomerulonephritis MPGN. | |||
== Historical Prespective == | == Historical Prespective == | ||
* | *In 1946, Bell coined the term membranous glomerulonephritis. <ref name="Glassock2010">{{cite journal|last1=Glassock|first1=Richard J.|title=The Pathogenesis of Idiopathic Membranous Nephropathy: A 50-Year Odyssey|journal=American Journal of Kidney Diseases|volume=56|issue=1|year=2010|pages=157–167|issn=02726386|doi=10.1053/j.ajkd.2010.01.008}}</ref> | ||
*In 1957, David Jones, a renal pathologist from Syracuse University in New York, | *In 1957, David Jones, a renal pathologist from Syracuse University in New York, described membranous glomerulonephritis as a distinct morphologic entity. | ||
*Prof. Jones was the first to illustrate complete features of MPGN which include: | |||
**Lobular glomerulonephritis | |||
**Lipoid nephrosis | |||
**Chronic glomerulonephritis | |||
*He also described the characteristic thickening of the capillary wall and alteration in [[basement membrane]] structure. | |||
* | *In 1959, Movat and McGregor identified electron-dense subepithelial deposits using electron microscope. | ||
*In 1957, Mellors was the first to identify immunoglobulin deposits as the third component of membranous glomerulonephritis and later described the triad of MPGN. | |||
{{Membranoproliferative glomerulonephritis}} | {{Membranoproliferative glomerulonephritis}} | ||
Latest revision as of 00:58, 3 August 2018
|
Membranoproliferative glomerulonephritis Microchapters |
|
Differentiating Membranoproliferative glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Membranoproliferative glomerulonephritis historical perspective On the Web |
|
American Roentgen Ray Society Images of Membranoproliferative glomerulonephritis historical perspective |
|
FDA on Membranoproliferative glomerulonephritis historical perspective |
|
CDC on Membranoproliferative glomerulonephritis historical perspective |
|
Membranoproliferative glomerulonephritis historical perspective in the news |
|
Blogs on Membranoproliferative glomerulonephritis historical perspective |
|
Directions to Hospitals Treating Membranoproliferative glomerulonephritis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief:
Overview
The term membranous glomerulonephritis was used first by Bell in 1946 to describe a category of glomerular renal disease classified within the spectrum of Ellis type II glomerulonephritis. This category also included lipoid nephrosis, lobular glomerulonephritis, and chronic glomerulonephritis. In 1957, David Jones, a renal pathologist from Syracuse University in New York, separated membranous glomerulonephritis as a distinct morphologic entity. Jones fully illustrated the special features of this lesion such as lobular glomerulonephritis, lipoid nephrosis and chronic glomerulonephritis. Thickening of the capillary wall and alteration in basement membrane structure were described. Electron-dense subepithelial locations were identified by Movat and McGregor in 1959 using electron microscopic methods. Mellors in 1957 identified the unique lesion of membranous glomerulonephritis, the presence of immunoglobulin in the deposits, using the immunofluorescence technique. Thus, over the span of just 2 years, the triad of essential features of membranous glomerulonephritis were described. These are still the fundamental features used today to identify membranous glomerulonephritis, now called membranoproliferative glomerulonephritis MPGN.
Historical Prespective
- In 1946, Bell coined the term membranous glomerulonephritis. [1]
- In 1957, David Jones, a renal pathologist from Syracuse University in New York, described membranous glomerulonephritis as a distinct morphologic entity.
- Prof. Jones was the first to illustrate complete features of MPGN which include:
- Lobular glomerulonephritis
- Lipoid nephrosis
- Chronic glomerulonephritis
- He also described the characteristic thickening of the capillary wall and alteration in basement membrane structure.
- In 1959, Movat and McGregor identified electron-dense subepithelial deposits using electron microscope.
- In 1957, Mellors was the first to identify immunoglobulin deposits as the third component of membranous glomerulonephritis and later described the triad of MPGN.
|
Membranoproliferative glomerulonephritis Microchapters |
|
Differentiating Membranoproliferative glomerulonephritis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Membranoproliferative glomerulonephritis historical perspective On the Web |
|
American Roentgen Ray Society Images of Membranoproliferative glomerulonephritis historical perspective |
|
FDA on Membranoproliferative glomerulonephritis historical perspective |
|
CDC on Membranoproliferative glomerulonephritis historical perspective |
|
Membranoproliferative glomerulonephritis historical perspective in the news |
|
Blogs on Membranoproliferative glomerulonephritis historical perspective |
|
Directions to Hospitals Treating Membranoproliferative glomerulonephritis |
References
- ↑ Glassock, Richard J. (2010). "The Pathogenesis of Idiopathic Membranous Nephropathy: A 50-Year Odyssey". American Journal of Kidney Diseases. 56 (1): 157–167. doi:10.1053/j.ajkd.2010.01.008. ISSN 0272-6386.